Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 150

  • Showing results for dickinson am. Search instead for Dickenson AM (1 item)
1.

Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.

Dickinson AM, Norden J, Li S, Hromadnikova I, Schmid C, Schmetzer H, Jochem-Kolb H.

Front Immunol. 2017 Jun 7;8:496. doi: 10.3389/fimmu.2017.00496. eCollection 2017. Review.

2.

Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.

Gam R, Shah P, Crossland RE, Norden J, Dickinson AM, Dressel R.

Front Immunol. 2017 Apr 3;8:380. doi: 10.3389/fimmu.2017.00380. eCollection 2017. Review.

3.

IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo.

Boieri M, Ulvmoen A, Sudworth A, Lendrem C, Collin M, Dickinson AM, Kveberg L, Inngjerdingen M.

Oncoimmunology. 2017 Jan 17;6(3):e1274478. doi: 10.1080/2162402X.2016.1274478. eCollection 2017.

PMID:
28405496
4.

Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease.

Crossland RE, Norden J, Juric MK, Green K, Pearce KF, Lendrem C, Greinix HT, Dickinson AM.

Front Immunol. 2017 Mar 24;8:308. doi: 10.3389/fimmu.2017.00308. eCollection 2017.

5.

Pathophysiology of GvHD and Other HSCT-Related Major Complications.

Ghimire S, Weber D, Mavin E, Wang XN, Dickinson AM, Holler E.

Front Immunol. 2017 Mar 20;8:79. doi: 10.3389/fimmu.2017.00079. eCollection 2017. Review.

6.

Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts.

Green K, Pearce K, Sellar RS, Jardine L, Nicolson PL, Nagra S, Bigley V, Jackson G, Dickinson AM, Thomson K, Mackinnon S, Craddock C, Peggs KS, Collin M.

Biol Blood Marrow Transplant. 2017 May;23(5):805-812. doi: 10.1016/j.bbmt.2017.02.007. Epub 2017 Feb 14.

PMID:
28212937
7.

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Juric MK, Shevtsov M, Mozes P, Ogonek J, Crossland RE, Dickinson AM, Greinix HT, Holler E, Weissinger EM, Multhoff G.

Front Immunol. 2017 Jan 16;7:660. doi: 10.3389/fimmu.2016.00660. eCollection 2016. Review.

8.

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications.

Reis M, Ogonek J, Qesari M, Borges NM, Nicholson L, Preußner L, Dickinson AM, Wang XN, Weissinger EM, Richter A.

Front Immunol. 2016 Nov 14;7:500. eCollection 2016. Review.

9.

Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia.

Pearce KF, Balavarca Y, Norden J, Jackson G, Holler E, Dressel R, Greinix H, Toubert A, Gluckman E, Hromadnikova I, Sedlacek P, Wolff D, Holtick U, Bickeböller H, Dickinson AM.

Int J Immunogenet. 2016 Dec;43(6):404-412. doi: 10.1111/iji.12295. Epub 2016 Nov 9.

PMID:
27870355
10.

The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.

Weissinger EM, Human C, Metzger J, Hambach L, Wolf D, Greinix HT, Dickinson AM, Mullen W, Jonigk D, Kuzmina Z, Kreipe H, Schweier P, Böhm O, Türüchanow I, Ihlenburg-Schwarz D, Raad J, Durban A, Schiemann M, Könecke C, Diedrich H, Holler E, Beutel G, Krauter J, Ganser A, Stadler M.

Leukemia. 2017 Mar;31(3):654-662. doi: 10.1038/leu.2016.259. Epub 2016 Sep 28.

PMID:
27677743
11.

Cytomegalovirus-Specific T Cells Isolated by IFN-γ Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro.

Qesari M, Richter A, Ogonek J, Mischak-Weissinger E, Wang XN, Dickinson AM.

Transplantation. 2016 Nov;100(11):2352-2361.

PMID:
27152919
12.

Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat.

Jalapothu D, Boieri M, Crossland RE, Shah P, Butt IA, Norden J, Dressel R, Dickinson AM, Inngjerdingen M.

Front Immunol. 2016 Sep 16;7:361. eCollection 2016.

13.

Identification and validation of biomarkers associated with acute and chronic graft versus host disease.

Ahmed SS, Wang XN, Norden J, Pearce K, El-Gezawy E, Atarod S, Hromadnikova I, Collin M, Holler E, Dickinson AM.

Bone Marrow Transplant. 2016 Jun;51(6):890. doi: 10.1038/bmt.2016.125. No abstract available.

PMID:
27245090
14.

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.

Bell GM, Anderson AE, Diboll J, Reece R, Eltherington O, Harry RA, Fouweather T, MacDonald C, Chadwick T, McColl E, Dunn J, Dickinson AM, Hilkens CM, Isaacs JD.

Ann Rheum Dis. 2017 Jan;76(1):227-234. doi: 10.1136/annrheumdis-2015-208456. Epub 2016 Apr 26.

15.

miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence.

Atarod S, Ahmed MM, Lendrem C, Pearce KF, Cope W, Norden J, Wang XN, Collin M, Dickinson AM.

Front Immunol. 2016 Mar 8;7:56. doi: 10.3389/fimmu.2016.00056. eCollection 2016.

16.
17.

Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine.

Crossland RE, Norden J, Bibby LA, Davis J, Dickinson AM.

J Immunol Methods. 2016 Feb;429:39-49. doi: 10.1016/j.jim.2015.12.011. Epub 2015 Dec 23.

PMID:
26723490
18.

Identification and validation of biomarkers associated with acute and chronic graft versus host disease.

Ahmed SS, Wang XN, Norden J, Pearce K, El-Gezawy E, Atarod S, Hromadnikova I, Collin M, Holler E, Dickinson AM.

Bone Marrow Transplant. 2015 Dec;50(12):1563-71. doi: 10.1038/bmt.2015.191. Epub 2015 Sep 14.

PMID:
26367225
19.

An in vitro human skin test for assessing sensitization potential.

Ahmed SS, Wang XN, Fielding M, Kerry A, Dickinson I, Munuswamy R, Kimber I, Dickinson AM.

J Appl Toxicol. 2016 May;36(5):669-84. doi: 10.1002/jat.3197. Epub 2015 Aug 7.

PMID:
26251951
20.

Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?

Dickinson AM, Norden J.

Int J Immunogenet. 2015 Aug;42(4):229-38. doi: 10.1111/iji.12202. Epub 2015 May 23. Review.

PMID:
26010044

Supplemental Content

Loading ...
Support Center